Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological Acidosis

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619

Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431

Amyloid β-peptide is produced by cultured cells during normal metabolism

Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921

Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids

Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731

Amyloid β Protein Gene: cDNA, mRNA Distribution, and Genetic Linkage Near the Alzheimer Locus

Tanzi, R. E., Gusella, J. F., Watkins, P. C., Bruns, G. A. P., St George-Hyslop, P., Van Keuren, M. L., Patterson, D., Pagan, S., Kurnit, D. M., & Neve, R. L. (1987) · Science · doi:10.1126/science.2949367 · Cited by 1,611

Rapid induction of Alzheimer A beta amyloid formation by zinc

Bush, A., Pettingell, W., Multhaup, G., d Paradis, M., Vonsattel, J., Gusella, J., Beyreuther, K., Masters, C., & Tanzi, R. (1994) · Science · doi:10.1126/science.8073293 · Cited by 1,522

Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing

Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447

The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene

Tanzi, R. E., Petrukhin, K. E., Чернов, И. П., Pellequer, J., Wasco, W., Ross, B., Romano, D., Parano, E., Pavone, P., Brzustowicz, L. M., et al. (1993) · Nature Genetics · doi:10.1038/ng1293-344 · Cited by 1,367

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363

Alzheimer's disease & metals: therapeutic opportunities

Kenche, V. B., & Barnham, K. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01221.x · Cited by 147

Acceleration of Amyloid β-Peptide Aggregation by Physiological Concentrations of Calcium

Isaacs, A. M., Senn, D. B., Yuan, M., Shine, J. P., & Yankner, B. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602061200 · Cited by 149

Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis

Dedeoglu, A., Cormier, K., Payton, S., Tseitlin, K. A., Kremsky, J. N., Lai, L., Li, X., Moir, R. D., Tanzi, R. E., Bush, A. I., et al. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.08.016 · Cited by 141

Amyloid-β in Alzheimer Disease: The Null versus the Alternate Hypotheses

Lee, H., Zhu, X., Castellani, R. J., Nunomura, A., Perry, G. L., & Smith, M. A. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.114009 · Cited by 142

Iron: A Pathological Mediator of Alzheimer Disease?

Bishop, G. M., Robinson, S. R., Liu, Q., Perry, G. L., Atwood, C., & Smith, M. A. (2002) · Developmental Neuroscience · doi:10.1159/000065696 · Cited by 139

Structure and function of amyloid in Alzheimer's disease

Morgan, C., Colombres, M., Núñez, M. T., & Inestrosa, N. C. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.10.004 · Cited by 146

Histochemically Reactive Zinc in Plaques of the Swedish Mutant β-Amyloid Precursor Protein Transgenic Mice

Lee, J., Mook‐Jung, I., & Koh, J. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-11-j0002.1999 · Cited by 136

The effect of Cu2+ and Zn2+ on the Aβ42 peptide aggregation and cellular toxicity

Sharma, A. K., Pavlova, S. T., Kim, J., Kim, J., & Mirica, L. M. (2013) · Metallomics · doi:10.1039/c3mt00161j · Cited by 135

Metal exposure and Alzheimer’s pathogenesis

Liu, G., Huang, W., Moir, R. D., Vanderburg, C. R., Lai, B. C. H., Peng, Z., Tanzi, R. E., Rogers, J. T., & Huang, X. (2006) · Journal of Structural Biology · doi:10.1016/j.jsb.2005.12.011 · Cited by 135

Metal ions and oxidative protein modification in neurological disease.

Sayre, L. M., Moreira, P. I., Smith, M. A., & Perry, G. L. (2005) · PubMed · Cited by 135

Structural and thermodynamical properties of CuII amyloid-β16/28 complexes associated with Alzheimer’s disease

Guilloreau, L., Damian, L., Coppel, Y., Mazarguil, H., Winterhalter, M., & Faller, P. (2006) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-006-0154-1 · Cited by 134

Zinc, Carnosine, and Neurodegenerative Diseases

Kawahara, M., Tanaka, K.-I., & Kato-Negishi, M. (2018) · Nutrients · doi:10.3390/nu10020147 · Cited by 134

Alzheimer disease β-amyloid activity mimics cholesterol oxidase

Puglielli, L., Friedlich, A. L., Setchell, K. D. R., Nagano, S., Opazo, C., Cherny, R. A., Barnham, K. J., Wade, J. D., Melov, S., Kovacs, D. M., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23610 · Cited by 134

Engineering metal ion coordination to regulate amyloid fibril assembly and toxicity

Dong, J., Canfield, J. M., Mehta, A. K., Shokes, J. E., Tian, B., Childers, W. S., Simmons, J. A., Mao, Z., Scott, R. A., Warncke, K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702669104 · Cited by 134

Biometals and Their Therapeutic Implications in Alzheimer's Disease

Ayton, S., Lei, P., & Bush, A. I. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0312-z · Cited by 134

The Caenorhabditis elegans Aβ1–42 Model of Alzheimer Disease Predominantly Expresses Aβ3–42

McColl, G., Roberts, B. R., Gunn, A. P., Perez, K. A., Tew, D. J., Masters, C. L., Barnham, K. J., Cherny, R. A., & Bush, A. I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.c109.028514 · Cited by 131

Clioquinol Decreases Amyloid-β Burden and Reduces Working Memory Impairment in a Transgenic Mouse Model of Alzheimer's Disease

Grossi, C., Francese, S., Casini, A., Rosi, M. C., Luccarini, I., Fiorentini, A., Gabbiani, C., Luigi Messori, A., Moneti, G., & Casamenti, F. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1063 · Cited by 131

The Role of Iron and Copper in the Aetiology of Neurodegenerative Disorders

Perry, G. L., Sayre, L. M., Atwood, C., Castellani, R. J., Cash, A., Rottkamp, C. A., & Smith, M. A. (2002) · CNS Drugs · doi:10.2165/00023210-200216050-00006 · Cited by 130

Aluminum-triggered structural modifications and aggregation of β-amyloids

Ricchelli, F., Drago, D., Filippi, B., Tognon, G., & Zatta, P. F. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5141-0 · Cited by 128

Isoaspartate formation at position 23 of amyloid beta peptide enhanced fibril formation and deposited onto senile plaques and vascular amyloids in Alzheimer's disease

Shimizu, T., Fukuda, H., Murayama, S., Izumiyama, N., & Shirasawa, T. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10350 · Cited by 129

Bioinorganic Chemistry of Parkinson’s Disease: Structural Determinants for the Copper-Mediated Amyloid Formation of Alpha-Synuclein

Binolfi, A., Rodríguez, E. E., Valensin, D., D’Amelio, N., Ippoliti, E., Obal, G., Durán, R., Magistrato, A., Pritsch, O., Zweckstetter, M., et al. (2010) · Inorganic Chemistry · doi:10.1021/ic1016752 · Cited by 128

Copper, β-amyloid, and Alzheimer's disease: Tapping a sensitive connection

Bush, A. I., Masters, C. L., & Tanzi, R. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135061100 · Cited by 128

Iron and Mechanisms of Neurotoxicity

Salvador, G. A., Uranga, R. M., & Giusto, N. M. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2011/720658 · Cited by 131

Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer’s Disease

Uddin, M. S., Kabir, M. T., Rahman, M. S., Behl, T., Jeandet, P., Ashraf, G. M., Najda, A., Bin-Jumah, M. N., El-Seedi, H. R., & Abdel‐Daim, M. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165858 · Cited by 131

Decreased pH in the aging brain and Alzheimer's disease

Decker, Y., Németh, E., Schomburg, R., Chemla, A., Fülöp, L., Menger, M. D., Liu, Y., & Fassbender, K. C. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.12.007 · Cited by 129

Role of metal ions in aggregation of intrinsically disordered proteins in neurodegenerative diseases

Breydo, L., & Uversky, V. N. (2011) · Metallomics · doi:10.1039/c1mt00106j · Cited by 129

Signal transduction during amyloid-β-peptide neurotoxicity: role in Alzheimer disease

Fuentealba, R. A., Farı́as, G. G., Scheu, J., Bronfman, M., Marzolo, M., & Inestrosa, N. C. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.07.018 · Cited by 126

Amyloid plaques in PSAPP mice bind less metal than plaques in human Alzheimer's disease

Leskovjan, A. C., Lanzirotti, A., & Miller, L. M. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.05.063 · Cited by 129

Therapeutic Redistribution of Metal Ions To Treat Alzheimer’s Disease

Crouch, P. J., & Barnham, K. J. (2012) · Accounts of Chemical Research · doi:10.1021/ar300074t · Cited by 125

Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease

Bonda, D., Mailankot, M., Stone, J. G., Garrett, M. R., Staniszewska, M. M., Castellani, R. J., Siedlak, S. L., Zhu, X., Lee, H., Perry, G. L., et al. (2010) · Redox Report · doi:10.1179/174329210x12650506623645 · Cited by 126

Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?

Humpel, C. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.11.032 · Cited by 127

Sequestration of Copper from β-Amyloid Promotes Selective Lysis by Cyclen-Hybrid Cleavage Agents

Wu, W., Lei, P., Liu, Q. R., Hu, J., Gunn, A. P., Chen, M., Rui, Y., Su, X., Xie, Z., Zhao, Y., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804722200 · Cited by 124

Mesoporous Silica Nanoparticle‐based H2O2 Responsive Controlled‐Release System Used for Alzheimer's Disease Treatment

Geng, J., Li, M., Wu, L., Chen, C., & Qu, X. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200067 · Cited by 124

Blocking acid-sensing ion channel 1 alleviates Huntington's disease pathology via an ubiquitin-proteasome system-dependent mechanism

Wong, H. K., Bauer, P. O., Kurosawa, M., Goswami, A., Washizu, C., Machida, Y., Tosaki, A., Yamada, M., Knöpfel, T., Nakamura, T., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn218 · Cited by 126

The galvanization of β-amyloid in Alzheimer's disease

Bush, A. I., & Tanzi, R. E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122249699 · Cited by 122

A doença de Alzheimer: aspectos fisiopatológicos e farmacológicos

Sereniki, A., & Vital, M. A. B. F. (2008) · Revista de Psiquiatria do Rio Grande do Sul · doi:10.1590/s0101-81082008000200002 · Cited by 121

Cu(II) Mediates Kinetically Distinct, Non-amyloidogenic Aggregation of Amyloid-β Peptides

Pedersen, J. T., Østergaard, J., Rozlosnik, N., Gammelgaard, B., & Heegaard, N. H. H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.220863 · Cited by 123

Cu(II) Binding to Monomeric, Oligomeric, and Fibrillar Forms of the Alzheimer’s Disease Amyloid-β Peptide

Karr, J. W., & Szalai, V. A. (2008) · Biochemistry · doi:10.1021/bi702423h · Cited by 119

Pulsed hydrogen–deuterium exchange mass spectrometry probes conformational changes in amyloid beta (Aβ) peptide aggregation

Zhang, Y., Rempel, D. L., Zhang, J., Sharma, A. K., Mirica, L. M., & Gross, M. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309175110 · Cited by 118

Copper, Zinc, and the Metallobiology of Alzheimer Disease

Bush, A. I. (2003) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200307000-00005 · Cited by 117

Structural characterization of Cu2+, Ni2+ and Zn2+ binding sites of model peptides associated with neurodegenerative diseases

Migliorini, C., Porciatti, E., Łuczkowski, M., & Valensin, D. (2011) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2011.07.004 · Cited by 117

Oxidative stress mechanisms and potential therapeutics in Alzheimer disease

Moreira, P. I., Siedlak, S. L., Aliev, G., Zhu, X., Cash, A., Smith, M. A., & Perry, G. L. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0242-8 · Cited by 119

Effect of pH and Copper(II) on the Conformation Transitions of Silk Fibroin Based on EPR, NMR, and Raman Spectroscopy

Zong, X.-H., Zhou, P., Shao, Z., Chen, S., Chen, X., Hu, B., Deng, F., & Yao, W.-H. (2004) · Biochemistry · doi:10.1021/bi049455h · Cited by 116

Aggregation Pathways of the Amyloid β(1–42) Peptide Depend on Its Colloidal Stability and Ordered β-Sheet Stacking

Jiang, D., Rauda, I. E., Han, S., Chen, S., & Zhou, F. (2012) · Langmuir · doi:10.1021/la3021436 · Cited by 117

Leptin prevents hippocampal synaptic disruption and neuronal cell death induced by amyloid β

Doherty, G. H., Beccano-Kelly, D. A., Yan, S. D., Gunn‐Moore, F. J., & Harvey, J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.08.003 · Cited by 116

Quantification of the Binding Constant of Copper(II) to the Amyloid-Beta Peptide

Hatcher, L. Q., Hong, L., Bush, W. D., Carducci, T. M., & Simon, J. D. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp710806s · Cited by 116

Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency

Stoltenberg, M., Bush, A. I., Bach, G., Smidt, K., Larsen, A., Rungby, J., Lund, S. A., Doering, P., & Danscher, G. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.09.025 · Cited by 114

Iron-induced oxidative stress modify tau phosphorylation patterns in hippocampal cell cultures

Egaña, J. T., Zambrano, C. A., Núñez, M. T., González-Billault, C. E., & Maccioni, R. B. (2003) · BioMetals · doi:10.1023/a:1020727218493 · Cited by 114

Cu and Zn interactions with Aβ peptides: consequence of coordination on aggregation and formation of neurotoxic soluble Aβ oligomers

Rana, M., & Sharma, A. K. (2018) · Metallomics · doi:10.1039/c8mt00203g · Cited by 116

Examining the zinc binding site of the amyloid‐β peptide

Yang, D., McLaurin, J., Qin, K., Westaway, D. A., & Fraser, P. E. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01767.x · Cited by 113

Copper and Alzheimer’s Disease

Mathys, Z. K., & White, A. R. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-60189-2_10 · Cited by 115

Aβ delays fibrin clot lysis by altering fibrin structure and attenuating plasminogen binding to fibrin.

Zamolodchikov, D., & Strickland, S. (2012) · Blood · doi:10.1182/blood-2011-11-389668 · Cited by 109

Differential Effects of Apolipoprotein E Isoforms on Metal-Induced Aggregation of Aβ Using Physiological Concentrations

Moir, R. D., Atwood, C., Romano, D., Laurans, M. H., Huang, X., Bush, A. I., Smith, J. D., & Tanzi, R. E. (1999) · Biochemistry · doi:10.1021/bi982437d · Cited by 112

Zinc dyshomeostasis: A key modulator of neuronal injury

Capasso, M., Jeng, J., Malavolta, M., Mocchegiani, E., & Sensi, S. L. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-8202 · Cited by 110

Effects of Cyclen and Cyclam on Zinc(II)- and Copper(II)-Induced Amyloid β-Peptide Aggregation and Neurotoxicity

Chen, T., Wang, X., He, Y., Zhang, C., Wu, Z., Liao, K., Wang, J., & Guo, Z. (2009) · Inorganic Chemistry · doi:10.1021/ic900025x · Cited by 110

Endogenous mechanisms of neuroprotection: role of zinc, copper, and carnosine

Horning, M. S., Blakemore, L. J., & Trombley, P. Q. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02215-5 · Cited by 109

NMR mapping of copper binding sites in alpha-synuclein

Sung, Y., Rospigliosi, C. C., & Eliezer, D. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.11.003 · Cited by 109

Oxidative Stress in Alzheimer’s Disease: Should We Keep Trying Antioxidant Therapies?

Ferreira, M. E. S., de Vasconcelos, A. S., Vilhena, T. D. C., da Silva, T. L., Barbosa, A. D. S., Gomes, A. R. Q., Dolabela, M. F., & Percário, S. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0157-y · Cited by 111

Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease

Squitti, R., Ghidoni, R., Siotto, M., Ventriglia, M., Benussi, L., Paterlini, A., Magri, M., Binetti, G. G., Cassetta, E., Caprara, D., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24136 · Cited by 108

Aluminium and iron, but neither copper nor zinc, are key to the precipitation of β-sheets of Aβ42 in senile plaque cores in Alzheimer's disease

Exley, C. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-102-305 · Cited by 107

β‐Amyloid protein oligomers induced by metal ions and acid pH are distinct from those generated by slow spontaneous ageing at neutral pH

Klug, G. M., Lošić, D., Supundi, Subasinghe, S., Aguilar, M., Martin, L. L., & Small, D. H. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03815.x · Cited by 109

Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases

Cahill, C. M., Lahiri, D. K., Huang, X., & Rogers, J. T. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.12.001 · Cited by 108

Mitochondrial Dynamics in Alzheimerʼs Disease

Bonda, D., Wang, X., Perry, G. L., Smith, M. A., & Zhu, X. (2010) · Drugs & Aging · doi:10.2165/11532140-000000000-00000 · Cited by 106

Organelle-selective fluorescent Cu 2+ ion probes: revealing the endoplasmic reticulum as a reservoir for Cu-overloading

Lee, Y. H., Park, N., Park, Y. B., Hwang, Y. J., Kang, C., & Kim, J. S. (2014) · Chemical Communications · doi:10.1039/c4cc00091a · Cited by 105

Inhibiting Aggregation of α-Synuclein with Human Single Chain Antibody Fragments

Emadi, S., Liu, R., Yuan, B., Schulz, P., McAllister, C., Lyubchenko, Y. L., Messer, A. C., & Sierks, M. R. (2004) · Biochemistry · doi:10.1021/bi036281f · Cited by 104

Novel Chelators for Central Nervous System Disorders That Involve Alterations in the Metabolism of Iron and Other Metal Ions

Richardson, D. R. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.026 · Cited by 104

Metal binding sites in amyloid oligomers: Complexes and mechanisms

Miller, Y., Ma, B., & Nussinov, R. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2011.12.022 · Cited by 103

The therapeutic importance of acid-base balance

Quade, B. N., Parker, M. D., & Occhipinti, R. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114278 · Cited by 108

Metal ion transporters in mammals: structure, function and pathological implications

Rolfs, A., & Hediger, M. A. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.0001r.x · Cited by 103

Selective destabilization of soluble amyloid β oligomers by divalent metal ions

Garai, K., Sengupta, P., Sahoo, B., & Maiti, S. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.056 · Cited by 102

NMR Studies of the Zn 2+ Interactions with Rat and Human β-Amyloid (1−28) Peptides in Water-Micelle Environment

Gaggelli, E., Janicka-Kłos, A., Jankowska, E., Kozłowski, H., Migliorini, C., Molteni, E., Valensin, D., Valensin, G., & Wieczerzak, E. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp075168m · Cited by 102

Structural Characterization of Binding of Cu(II) to Tau Protein

Soragni, A., Zambelli, B., Mukrasch, M. D., Biernat, J., Jeganathan�, S., Griesinger, C., Ciurli, S., Mandelkow�, E., & Zweckstetter, M. (2008) · Biochemistry · doi:10.1021/bi8008856 · Cited by 104

Molecular Dynamics Study of Zn(Aβ) and Zn(Aβ)2

Pan, L., & Patterson, J. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070681 · Cited by 102

Biophysical Studies of the Amyloid β‐Peptide: Interactions with Metal Ions and Small Molecules

Wärmländer, S. K. T. S., Tiiman, A., Abelein, A., Luo, J., Jarvet, J., Söderberg, K. L., Danielsson, J., & Gräslund, A. (2013) · ChemBioChem · doi:10.1002/cbic.201300262 · Cited by 104

Altered microglial copper homeostasis in a mouse model of Alzheimer’s disease

Zheng, Z., White, C., Lee, J., Peterson, T. S., Bush, A. I., Sun, G. Y., Weisman, G. A., & Petris, M. J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06888.x · Cited by 103

Structures of the Amyloid β-Peptides Aβ1–40 and Aβ1–42 as Influenced by pH and a d -Peptide

Olubiyi, O. O., & Strodel, B. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp2076337 · Cited by 100

Metallomic Profiling and Linkage Map Analysis of Early Parkinson's Disease: A New Insight to Aluminum Marker for the Possible Diagnosis

Ahmed, S. S. S. J., & Santosh, W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011252 · Cited by 103

Aβ40, either Soluble or Aggregated, Is a Remarkably Potent Antioxidant in Cell-Free Oxidative Systems

Baruch-Suchodolsky, R., & Fischer, B. (2009) · Biochemistry · doi:10.1021/bi802361k · Cited by 98

Diagnostic Imaging Agents for Alzheimer’s Disease: Copper Radiopharmaceuticals that Target Aβ Plaques

Hickey, J. L., Lim, S., Hayne, D. J., Paterson, B. M., White, J. M., Villemagne, V. L., Roselt, P. D., Binns, D., Cullinane, C. M., Jeffery, C. M., et al. (2013) · Journal of the American Chemical Society · doi:10.1021/ja4057807 · Cited by 98

A Diet Enriched in Polyphenols and Polyunsaturated Fatty Acids, LMN Diet, Induces Neurogenesis in the Subventricular Zone and Hippocampus of Adult Mouse Brain

Valente, T., Hidalgo, J., Bolea, I., Ramírez, B., Anglès, N., Reguant, J., Morelló, J. R., Gutiérrez, C., Boada, M., & Unzeta, M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1188 · Cited by 105

Estrogen Decreases Zinc Transporter 3 Expression and Synaptic Vesicle Zinc Levels in Mouse Brain

Lee, J., Kim, J.-H., Hong, S. H., Lee, J. Y., Cherny, R. A., Bush, A. I., Palmiter, R. D., & Koh, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309730200 · Cited by 98

Delineating common molecular mechanisms in Alzheimer's and prion diseases

Barnham, K. J., Cappai, R., Beyreuther, K. T., Masters, C. L., & Hill, A. F. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.06.006 · Cited by 97

The amyloid‐β peptide and its role in Alzheimer's disease

Clippingdale, A. B., Wade, J. D., & Barrow, C. J. (2001) · Journal of Peptide Science · doi:10.1002/psc.324 · Cited by 103

Neurodegeneration and oxidative stress: prion disease results from loss of antioxidant defence.

Brown, D. R. (2005) · PubMed · Cited by 97

Neuroprotective approaches in experimental models of β-Amyloid neurotoxicity: Relevance to Alzheimer's disease

Harkany, T., Hortobágyi, T., Sasvári, M., Kónya, C., Penke, B., Luiten, P. G. M., & Nyakas, C. J. (1999) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(99)00058-5 · Cited by 97

Exogenous induction of cerebral β-amyloidosis in βAPP-transgenic mice

Walker, L. C., Callahan, M. J., Bian, F., Durham, R. A., Roher, A. E., & Lipinski, W. J. (2002) · Peptides · doi:10.1016/s0196-9781(02)00059-1 · Cited by 96

Mechanisms by which metals promote events connected to neurodegenerative diseases

Campbell, A., Smith, M. A., Sayre, L. M., Bondy, S. C., & Perry, G. L. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00455-5 · Cited by 96

Structure of β-amyloid fibrils and its relevance to their neurotoxicity: Implications for the pathogenesis of Alzheimer’s disease

Irie, K., Murakami, K., Masuda, Y., Morimoto, A., Ohigashi, H., Ohashi, R., Takegoshi, K., Nagao, M., Shimizu, T., & Shirasawa, T. (2005) · Journal of Bioscience and Bioengineering · doi:10.1263/jbb.99.437 · Cited by 104

Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: Implications for Alzheimer β-amyloid pathology

Maynard, C. J., Cappai, R., Volitakis, I., Cherny, R. A., Masters, C. L., Li, Q., & Bush, A. I. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.02.010 · Cited by 97

Amyloid‐Beta Peptide Forms Monomeric Complexes With CuII and ZnII Prior to Aggregation

Talmard, C., Guilloreau, L., Coppel, Y., Mazarguil, H., & Faller, P. (2006) · ChemBioChem · doi:10.1002/cbic.200600319 · Cited by 96

Amyloid β Peptides Do Not Form Peptide-derived Free Radicals Spontaneously, but Can Enhance Metal-catalyzed Oxidation of Hydroxylamines to Nitroxides

Dikalov, S., Vitek, M. P., Maples, K. R., & Mason, R. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9392 · Cited by 96

Physiological Roles of Amyloid-?? and Implications for its Removal in Alzheimer???s Disease

Bishop, G. M., & Robinson, S. R. (2004) · Drugs & Aging · doi:10.2165/00002512-200421100-00001 · Cited by 94

The Metal Loading Ability of β-Amyloid N-Terminus: A Combined Potentiometric and Spectroscopic Study of Copper(II) Complexes with β-Amyloid(1−16), Its Short or Mutated Peptide Fragments, and Its Polyethylene Glycol (PEG)-ylated Analogue

Damante, C. A., Ösz, K., Nagy, Z., Pappalardo, G., Grasso, G., Impellizzeri, G., Rizzarelli, E., & Sóvágó, I. (2008) · Inorganic Chemistry · doi:10.1021/ic8006052 · Cited by 94

Development of an Efficient Biosensor for the In Vivo Monitoring of Cu+ and pH in the Brain: Rational Design and Synthesis of Recognition Molecules

Liu, W., Dong, H. Y., Zhang, L., & Tian, Y. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201710863 · Cited by 94

α2-Macroglobulin and Haptoglobin Suppress Amyloid Formation by Interacting with Prefibrillar Protein Species

Yerbury, J. J., Kumita, J. R., Meehan, S., Dobson, C. M., & Wilson, M. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807242200 · Cited by 95

Zinc in Alzheimer’s Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies

Ventriglia, M., Brewer, G. J., Simonelli, I., Mariani, S., Siotto, M., Bucossi, S., & Squitti, R. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141296 · Cited by 94

The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease

Drew, S. C. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00317 · Cited by 93

Amyloid plaques beyond Aβ: a survey of the diverse modulators of amyloid aggregation

Stewart, K. L., & Radford, S. E. (2017) · Biophysical Reviews · doi:10.1007/s12551-017-0271-9 · Cited by 95

Substitution of isoleucine-31 by helical-breaking proline abolishes oxidative stress and neurotoxic properties of Alzheimer’s amyloid β-peptide (1–42)

Kański, J., Aksenova, M. V., Schöneich, C., & Butterfield, D. A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00821-3 · Cited by 93

Prion Disease: A Loss of Antioxidant Function?

Wong, B., Pan, T., Liu, T., Li, R., Petersen, R. B., Jones, I. M., Gambetti, P. L., Brown, D. R., & Sy, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3158 · Cited by 93

Metal Binding Modes of Alzheimer's Amyloid β-Peptide in Insoluble Aggregates and Soluble Complexes

Miura, T., Suzuki, K., Kohata, N., & Takeuchi, H. (2000) · Biochemistry · doi:10.1021/bi0002479 · Cited by 457

Roles of Cu2+ in the conformational transitions and dimerization of amyloid-beta peptide and its implications in Alzheimer's disease

Liao, Q. (2016)

Inhibitory Effect of Copper(II) on Zinc(II)-Induced Aggregation of Amyloid β-Peptide

Suzuki, K., Miura, T., & Takeuchi, H. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5263 · Cited by 90

pH-dependence of the specific binding of Cu(II) and Zn(II) ions to the amyloid-β peptide

Ghalebani, L., Wahlström, A., Danielsson, J., Wärmländer, S. K. T. S., & Gräslund, A. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.04.043 · Cited by 48

Binding of zinc(II) and copper(II) to the full‐length Alzheimer’s amyloid‐β peptide

Tõugu, V., Tiiman, A., & Palumaa, P. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05061.x · Cited by 219